Diabetes 51:1194-1200, 2002
© 2002 by the American Diabetes Association, Inc.
Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells
Implications for Diabetes-Associated Cardiovascular Disease
Stuart J. Netherton1,
Sandra L. Jimmo1,
Daniel Palmer1,
Douglas G. Tilley1,
Heather A. Dunkerley1,
Daniel R. Raymond1,
James C. Russell2,
P. Marlene Absher3,
E. Helene Sage4,
Robert B. Vernon4, and
Donald H. Maurice1
1 Department of Pharmacology and Toxicology, Queens University, Kingston, Ontario, Canada
2 Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
3 Department of Medicine, University of Vermont, Burlington, Vermont
4 Hope Heart Institute, Seattle, Washington
Cardiovascular diseases represent a significant cause of morbidity and mortality in diabetes. Of the many animal models used in the study of non-insulin-dependent (type 2) diabetes, the JCR:LA-cp rat is unique in that it develops insulin resistance in the presence of obesity and manifests both peripheral and coronary vasculopathies. In this animal model, arterial vascular smooth muscle cells (VSMCs) from homozygous obese (cp/cp) rats, but not from age-matched healthy (+/+ or + /cp, collectively defined +/?) littermates, display an " activated" phenotype in vitro and in vivo and have an elevated level of cAMP phosphodiesterase (PDE) activity. In this report, we confirm that cp/cp rat aortic VSMCs have an elevated level of PDE3 activity and show that only particulate PDE3 (PDE3B) activity is elevated. In marked contrast to results obtained in + /? VSMCs, simultaneous activation of adenylyl cyclase and inhibition of PDE3 activity in cp/cp VSMCs synergistically increased cAMP. Although PDE3 inhibition did not potentiate the antimigratory effects of forskolin on +/? VSMCs, PDE3 inhibition did markedly potentiate the forskolin-induced inhibition of migration of cp/cp-derived VSMCs. Although PDE3 activity was elevated in cp/cp rat aortic VSMCs, levels of expression of cytosolic PDE3 (PDE3A) and PDE3B in +/? and cp/cp VSMCs, as well as activation of these enzymes following activation of the cAMP-protein kinase A signaling cascade, were not different. Our data are consistent with an increased role for PDE3 in regulating cAMP-dependent signaling in cp/cp VSMCs and identify PDE3 as a cellular activity potentially responsible for the phenotype of cp/cp VSMCs.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Matsumoto, T. Kobayashi, K. Wakabayashi, and K. Kamata
Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1933 - H1940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H2234 - H2243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Elbatarny and D. H. Maurice
Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex
Am J Physiol Endocrinol Metab,
October 1, 2005;
289(4):
E695 - E702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Netherton and D. H. Maurice
Vascular Endothelial Cell Cyclic Nucleotide Phosphodiesterases and Regulated Cell Migration: Implications in Angiogenesis
Mol. Pharmacol.,
January 1, 2005;
67(1):
263 - 272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1064 - H1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Maurice, D. Palmer, D. G. Tilley, H. A. Dunkerley, S. J. Netherton, D. R. Raymond, H. S. Elbatarny, and S. L. Jimmo
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
Mol. Pharmacol.,
September 1, 2003;
64(3):
533 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, T. Kobayashi, and K. Kamata
Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H283 - H291.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|